nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—ABCC3—Rifampicin—leprosy	0.11	0.135	CbGbCtD
Cyclosporine—ABCB11—Rifampicin—leprosy	0.0952	0.116	CbGbCtD
Cyclosporine—ABCC1—Rifampicin—leprosy	0.0676	0.0827	CbGbCtD
Cyclosporine—SLCO1A2—Rifampicin—leprosy	0.0604	0.0738	CbGbCtD
Cyclosporine—SLCO1B1—Rifampicin—leprosy	0.057	0.0696	CbGbCtD
Cyclosporine—ABCC2—Rifampicin—leprosy	0.0501	0.0612	CbGbCtD
Cyclosporine—CYP3A7—Rifampicin—leprosy	0.0334	0.0409	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.0334	0.0409	CbGbCtD
Cyclosporine—CYP3A7—Dapsone—leprosy	0.0276	0.0337	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0276	0.0337	CbGbCtD
Cyclosporine—CYP3A5—Thalidomide—leprosy	0.0259	0.0316	CbGbCtD
Cyclosporine—CYP3A5—Rifampicin—leprosy	0.0251	0.0306	CbGbCtD
Cyclosporine—CYP2C8—Rifampicin—leprosy	0.0241	0.0295	CbGbCtD
Cyclosporine—CYP2C19—Thalidomide—leprosy	0.0209	0.0255	CbGbCtD
Cyclosporine—CYP3A5—Dapsone—leprosy	0.0207	0.0253	CbGbCtD
Cyclosporine—CYP2C19—Rifampicin—leprosy	0.0202	0.0247	CbGbCtD
Cyclosporine—CYP2C8—Dapsone—leprosy	0.0199	0.0243	CbGbCtD
Cyclosporine—CYP2C9—Thalidomide—leprosy	0.0174	0.0212	CbGbCtD
Cyclosporine—CYP2C9—Rifampicin—leprosy	0.0168	0.0206	CbGbCtD
Cyclosporine—CYP2C19—Dapsone—leprosy	0.0167	0.0204	CbGbCtD
Cyclosporine—ABCB1—Rifampicin—leprosy	0.0163	0.0199	CbGbCtD
Cyclosporine—CYP2C9—Dapsone—leprosy	0.0139	0.017	CbGbCtD
Cyclosporine—CYP3A4—Rifampicin—leprosy	0.00978	0.0119	CbGbCtD
Cyclosporine—CYP3A4—Dapsone—leprosy	0.00807	0.00986	CbGbCtD
Cyclosporine—Hodgkin's disease lymphocyte predominance type stage unspecified—Thalidomide—leprosy	0.00765	0.0586	CcSEcCtD
Cyclosporine—Gingival disorder—Thalidomide—leprosy	0.00765	0.0586	CcSEcCtD
Cyclosporine—Hodgkin's disease—Thalidomide—leprosy	0.00765	0.0586	CcSEcCtD
Cyclosporine—Hodgkin's disease lymphocyte depletion type stage unspecified—Thalidomide—leprosy	0.00765	0.0586	CcSEcCtD
Cyclosporine—Posterior reversible encephalopathy syndrome—Thalidomide—leprosy	0.00439	0.0336	CcSEcCtD
Cyclosporine—Consciousness abnormal—Thalidomide—leprosy	0.00416	0.0318	CcSEcCtD
Cyclosporine—PPP3R2—testis—leprosy	0.00311	0.0641	CbGeAlD
Cyclosporine—Swelling face—Dapsone—leprosy	0.00296	0.0227	CcSEcCtD
Cyclosporine—Polyneuropathy—Thalidomide—leprosy	0.00221	0.0169	CcSEcCtD
Cyclosporine—FKBP4—eye—leprosy	0.00215	0.0444	CbGeAlD
Cyclosporine—FKBP4—skin of body—leprosy	0.00187	0.0386	CbGeAlD
Cyclosporine—FKBP1B—testis—leprosy	0.00178	0.0368	CbGeAlD
Cyclosporine—PPIA—eye—leprosy	0.00178	0.0368	CbGeAlD
Cyclosporine—FKBP1B—nervous system—leprosy	0.00175	0.0361	CbGeAlD
Cyclosporine—Altered state of consciousness—Thalidomide—leprosy	0.00156	0.012	CcSEcCtD
Cyclosporine—PPIF—eye—leprosy	0.00144	0.0298	CbGeAlD
Cyclosporine—FKBP4—tendon—leprosy	0.00142	0.0294	CbGeAlD
Cyclosporine—PPIB—eye—leprosy	0.00137	0.0284	CbGeAlD
Cyclosporine—PPID—tendon—leprosy	0.00131	0.0271	CbGeAlD
Cyclosporine—CAMLG—tendon—leprosy	0.0013	0.0268	CbGeAlD
Cyclosporine—PPIF—skin of body—leprosy	0.00126	0.0259	CbGeAlD
Cyclosporine—Gastric ulcer—Thalidomide—leprosy	0.00124	0.0095	CcSEcCtD
Cyclosporine—PPIB—skin of body—leprosy	0.0012	0.0247	CbGeAlD
Cyclosporine—PPIA—tendon—leprosy	0.00118	0.0244	CbGeAlD
Cyclosporine—FKBP4—testis—leprosy	0.00118	0.0244	CbGeAlD
Cyclosporine—Serum creatinine increased—Thalidomide—leprosy	0.00117	0.00898	CcSEcCtD
Cyclosporine—FKBP4—nervous system—leprosy	0.00116	0.0239	CbGeAlD
Cyclosporine—Psoriasis—Thalidomide—leprosy	0.00115	0.00879	CcSEcCtD
Cyclosporine—Hypomagnesaemia—Thalidomide—leprosy	0.00113	0.00869	CcSEcCtD
Cyclosporine—Tooth disorder—Thalidomide—leprosy	0.00111	0.00851	CcSEcCtD
Cyclosporine—Nail disorder—Thalidomide—leprosy	0.00111	0.00851	CcSEcCtD
Cyclosporine—PPID—testis—leprosy	0.00109	0.0225	CbGeAlD
Cyclosporine—CAMLG—testis—leprosy	0.00107	0.0222	CbGeAlD
Cyclosporine—PPID—nervous system—leprosy	0.00107	0.0221	CbGeAlD
Cyclosporine—Menstrual disorder—Thalidomide—leprosy	0.00106	0.0081	CcSEcCtD
Cyclosporine—CAMLG—nervous system—leprosy	0.00105	0.0217	CbGeAlD
Cyclosporine—Burning sensation—Thalidomide—leprosy	0.00104	0.00795	CcSEcCtD
Cyclosporine—Interstitial lung disease—Thalidomide—leprosy	0.00102	0.0078	CcSEcCtD
Cyclosporine—Thrombosis—Thalidomide—leprosy	0.00102	0.0078	CcSEcCtD
Cyclosporine—Hyperlipidaemia—Thalidomide—leprosy	0.001	0.00766	CcSEcCtD
Cyclosporine—PPIA—testis—leprosy	0.000977	0.0202	CbGeAlD
Cyclosporine—PPIF—tendon—leprosy	0.000956	0.0197	CbGeAlD
Cyclosporine—Cholestasis—Thalidomide—leprosy	0.000949	0.00727	CcSEcCtD
Cyclosporine—Skin ulcer—Thalidomide—leprosy	0.000926	0.00709	CcSEcCtD
Cyclosporine—Hyperaesthesia—Thalidomide—leprosy	0.000918	0.00704	CcSEcCtD
Cyclosporine—FKBP1A—eye—leprosy	0.000918	0.019	CbGeAlD
Cyclosporine—PPP3CA—tendon—leprosy	0.000915	0.0189	CbGeAlD
Cyclosporine—PPIB—tendon—leprosy	0.00091	0.0188	CbGeAlD
Cyclosporine—Muscular weakness—Dapsone—leprosy	0.000901	0.00691	CcSEcCtD
Cyclosporine—Tingling sensation—Thalidomide—leprosy	0.000897	0.00687	CcSEcCtD
Cyclosporine—Pancreatitis—Dapsone—leprosy	0.000866	0.00664	CcSEcCtD
Cyclosporine—Acne—Thalidomide—leprosy	0.000857	0.00656	CcSEcCtD
Cyclosporine—Amenorrhoea—Thalidomide—leprosy	0.00082	0.00628	CcSEcCtD
Cyclosporine—Musculoskeletal stiffness—Thalidomide—leprosy	0.000803	0.00616	CcSEcCtD
Cyclosporine—FKBP1A—skin of body—leprosy	0.000799	0.0165	CbGeAlD
Cyclosporine—Viral infection—Thalidomide—leprosy	0.000798	0.00611	CcSEcCtD
Cyclosporine—Hyperbilirubinaemia—Thalidomide—leprosy	0.000793	0.00607	CcSEcCtD
Cyclosporine—Arthropathy—Thalidomide—leprosy	0.000793	0.00607	CcSEcCtD
Cyclosporine—Cellulitis—Thalidomide—leprosy	0.000793	0.00607	CcSEcCtD
Cyclosporine—PPIF—testis—leprosy	0.000792	0.0163	CbGeAlD
Cyclosporine—Herpes simplex—Thalidomide—leprosy	0.000782	0.00599	CcSEcCtD
Cyclosporine—Hyperuricaemia—Thalidomide—leprosy	0.000777	0.00595	CcSEcCtD
Cyclosporine—PPIF—nervous system—leprosy	0.000777	0.016	CbGeAlD
Cyclosporine—Neuropathy peripheral—Dapsone—leprosy	0.000772	0.00591	CcSEcCtD
Cyclosporine—PPP3CA—testis—leprosy	0.000758	0.0156	CbGeAlD
Cyclosporine—Creatinine increased—Thalidomide—leprosy	0.000757	0.0058	CcSEcCtD
Cyclosporine—Hearing impaired—Thalidomide—leprosy	0.000757	0.0058	CcSEcCtD
Cyclosporine—PPIB—testis—leprosy	0.000753	0.0156	CbGeAlD
Cyclosporine—PPP3CA—nervous system—leprosy	0.000744	0.0154	CbGeAlD
Cyclosporine—PPIB—nervous system—leprosy	0.000739	0.0153	CbGeAlD
Cyclosporine—Sinusitis—Dapsone—leprosy	0.000739	0.00566	CcSEcCtD
Cyclosporine—Blood uric acid increased—Thalidomide—leprosy	0.000734	0.00562	CcSEcCtD
Cyclosporine—Hepatocellular injury—Thalidomide—leprosy	0.000721	0.00552	CcSEcCtD
Cyclosporine—Eructation—Thalidomide—leprosy	0.000708	0.00543	CcSEcCtD
Cyclosporine—Hyperkalaemia—Thalidomide—leprosy	0.000708	0.00543	CcSEcCtD
Cyclosporine—Pharyngitis—Dapsone—leprosy	0.000702	0.00538	CcSEcCtD
Cyclosporine—Candida infection—Thalidomide—leprosy	0.000688	0.00527	CcSEcCtD
Cyclosporine—Blood urea increased—Thalidomide—leprosy	0.00068	0.00521	CcSEcCtD
Cyclosporine—Neuropathy—Thalidomide—leprosy	0.000677	0.00518	CcSEcCtD
Cyclosporine—Cramps of lower extremities—Thalidomide—leprosy	0.000662	0.00507	CcSEcCtD
Cyclosporine—Tinnitus—Dapsone—leprosy	0.000659	0.00505	CcSEcCtD
Cyclosporine—Oesophagitis—Thalidomide—leprosy	0.000659	0.00505	CcSEcCtD
Cyclosporine—Gynaecomastia—Thalidomide—leprosy	0.000645	0.00494	CcSEcCtD
Cyclosporine—SLC10A1—testis—leprosy	0.000644	0.0133	CbGeAlD
Cyclosporine—ABCB11—testis—leprosy	0.000637	0.0132	CbGeAlD
Cyclosporine—SLC10A1—nervous system—leprosy	0.000632	0.0131	CbGeAlD
Cyclosporine—Mental disability—Thalidomide—leprosy	0.000625	0.00479	CcSEcCtD
Cyclosporine—Sepsis—Thalidomide—leprosy	0.000625	0.00479	CcSEcCtD
Cyclosporine—Lymphadenopathy—Thalidomide—leprosy	0.000613	0.0047	CcSEcCtD
Cyclosporine—FKBP1A—tendon—leprosy	0.000608	0.0126	CbGeAlD
Cyclosporine—Diabetes mellitus—Thalidomide—leprosy	0.000601	0.00461	CcSEcCtD
Cyclosporine—Gastroenteritis—Thalidomide—leprosy	0.00059	0.00452	CcSEcCtD
Cyclosporine—Deafness—Thalidomide—leprosy	0.000585	0.00448	CcSEcCtD
Cyclosporine—Vascular purpura—Thalidomide—leprosy	0.000585	0.00448	CcSEcCtD
Cyclosporine—Eczema—Thalidomide—leprosy	0.000582	0.00446	CcSEcCtD
Cyclosporine—Vision blurred—Dapsone—leprosy	0.00058	0.00444	CcSEcCtD
Cyclosporine—Eye pain—Thalidomide—leprosy	0.00058	0.00444	CcSEcCtD
Cyclosporine—Injury—Thalidomide—leprosy	0.000569	0.00436	CcSEcCtD
Cyclosporine—Libido decreased—Thalidomide—leprosy	0.000564	0.00432	CcSEcCtD
Cyclosporine—Increased appetite—Thalidomide—leprosy	0.000557	0.00427	CcSEcCtD
Cyclosporine—Vertigo—Dapsone—leprosy	0.000553	0.00424	CcSEcCtD
Cyclosporine—Visual disturbance—Thalidomide—leprosy	0.000552	0.00423	CcSEcCtD
Cyclosporine—Dermatitis bullous—Thalidomide—leprosy	0.000547	0.00419	CcSEcCtD
Cyclosporine—Purpura—Thalidomide—leprosy	0.000543	0.00416	CcSEcCtD
Cyclosporine—Arthritis—Thalidomide—leprosy	0.000538	0.00412	CcSEcCtD
Cyclosporine—Cough—Dapsone—leprosy	0.000537	0.00411	CcSEcCtD
Cyclosporine—Hypoglycaemia—Thalidomide—leprosy	0.000536	0.00411	CcSEcCtD
Cyclosporine—Cardiac failure—Thalidomide—leprosy	0.000536	0.00411	CcSEcCtD
Cyclosporine—Lethargy—Thalidomide—leprosy	0.000534	0.00409	CcSEcCtD
Cyclosporine—Osteoarthritis—Thalidomide—leprosy	0.000523	0.00401	CcSEcCtD
Cyclosporine—Disturbance in sexual arousal—Thalidomide—leprosy	0.000519	0.00398	CcSEcCtD
Cyclosporine—Migraine—Thalidomide—leprosy	0.000515	0.00395	CcSEcCtD
Cyclosporine—Affect lability—Thalidomide—leprosy	0.000515	0.00395	CcSEcCtD
Cyclosporine—FKBP1A—testis—leprosy	0.000504	0.0104	CbGeAlD
Cyclosporine—Mood swings—Thalidomide—leprosy	0.000496	0.0038	CcSEcCtD
Cyclosporine—FKBP1A—nervous system—leprosy	0.000494	0.0102	CbGeAlD
Cyclosporine—Blood creatinine increased—Thalidomide—leprosy	0.00049	0.00376	CcSEcCtD
Cyclosporine—ABCC10—tendon—leprosy	0.000487	0.0101	CbGeAlD
Cyclosporine—Dry skin—Thalidomide—leprosy	0.00048	0.00367	CcSEcCtD
Cyclosporine—Breast disorder—Thalidomide—leprosy	0.000473	0.00362	CcSEcCtD
Cyclosporine—Cramp muscle—Thalidomide—leprosy	0.000471	0.00361	CcSEcCtD
Cyclosporine—Muscular weakness—Thalidomide—leprosy	0.000461	0.00354	CcSEcCtD
Cyclosporine—Abdominal distension—Thalidomide—leprosy	0.000455	0.00349	CcSEcCtD
Cyclosporine—Insomnia—Dapsone—leprosy	0.000454	0.00348	CcSEcCtD
Cyclosporine—Dysphagia—Thalidomide—leprosy	0.000452	0.00346	CcSEcCtD
Cyclosporine—Bronchospasm—Thalidomide—leprosy	0.000445	0.00341	CcSEcCtD
Cyclosporine—PPIA—Binding and entry of HIV virion—CD4—leprosy	0.000444	0.163	CbGpPWpGaD
Cyclosporine—Pancreatitis—Thalidomide—leprosy	0.000443	0.0034	CcSEcCtD
Cyclosporine—Bronchitis—Thalidomide—leprosy	0.000435	0.00333	CcSEcCtD
Cyclosporine—Upper respiratory tract infection—Thalidomide—leprosy	0.00042	0.00322	CcSEcCtD
Cyclosporine—Pollakiuria—Thalidomide—leprosy	0.000418	0.0032	CcSEcCtD
Cyclosporine—Weight increased—Thalidomide—leprosy	0.000412	0.00315	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Dapsone—leprosy	0.000411	0.00315	CcSEcCtD
Cyclosporine—Weight decreased—Thalidomide—leprosy	0.000409	0.00313	CcSEcCtD
Cyclosporine—Hyperglycaemia—Thalidomide—leprosy	0.000408	0.00313	CcSEcCtD
Cyclosporine—Pneumonia—Thalidomide—leprosy	0.000406	0.00311	CcSEcCtD
Cyclosporine—ABCC3—testis—leprosy	0.000405	0.00837	CbGeAlD
Cyclosporine—ABCC10—testis—leprosy	0.000403	0.00833	CbGeAlD
Cyclosporine—Infestation NOS—Thalidomide—leprosy	0.000403	0.00309	CcSEcCtD
Cyclosporine—Infestation—Thalidomide—leprosy	0.000403	0.00309	CcSEcCtD
Cyclosporine—Depression—Thalidomide—leprosy	0.000402	0.00308	CcSEcCtD
Cyclosporine—ABCB1—blood vessel—leprosy	0.000399	0.00824	CbGeAlD
Cyclosporine—ABCC3—nervous system—leprosy	0.000398	0.00821	CbGeAlD
Cyclosporine—Acute coronary syndrome—Thalidomide—leprosy	0.000397	0.00305	CcSEcCtD
Cyclosporine—Abdominal pain—Dapsone—leprosy	0.000397	0.00304	CcSEcCtD
Cyclosporine—Body temperature increased—Dapsone—leprosy	0.000397	0.00304	CcSEcCtD
Cyclosporine—Renal failure—Thalidomide—leprosy	0.000396	0.00304	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Thalidomide—leprosy	0.000395	0.00303	CcSEcCtD
Cyclosporine—Myocardial infarction—Thalidomide—leprosy	0.000395	0.00303	CcSEcCtD
Cyclosporine—Stomatitis—Thalidomide—leprosy	0.000393	0.00301	CcSEcCtD
Cyclosporine—Conjunctivitis—Thalidomide—leprosy	0.000392	0.003	CcSEcCtD
Cyclosporine—ABCC2—tendon—leprosy	0.000391	0.00808	CbGeAlD
Cyclosporine—Haematuria—Thalidomide—leprosy	0.000384	0.00295	CcSEcCtD
Cyclosporine—Epistaxis—Thalidomide—leprosy	0.00038	0.00291	CcSEcCtD
Cyclosporine—Sinusitis—Thalidomide—leprosy	0.000378	0.0029	CcSEcCtD
Cyclosporine—Rhinitis—Thalidomide—leprosy	0.000363	0.00278	CcSEcCtD
Cyclosporine—Hepatitis—Thalidomide—leprosy	0.000362	0.00277	CcSEcCtD
Cyclosporine—Hypoaesthesia—Thalidomide—leprosy	0.00036	0.00276	CcSEcCtD
Cyclosporine—Pharyngitis—Thalidomide—leprosy	0.000359	0.00275	CcSEcCtD
Cyclosporine—Urinary tract disorder—Thalidomide—leprosy	0.000357	0.00274	CcSEcCtD
Cyclosporine—Urethral disorder—Thalidomide—leprosy	0.000355	0.00272	CcSEcCtD
Cyclosporine—Visual impairment—Thalidomide—leprosy	0.000349	0.00267	CcSEcCtD
Cyclosporine—SLCO1A2—testis—leprosy	0.000348	0.00718	CbGeAlD
Cyclosporine—ABCC1—tendon—leprosy	0.000345	0.00711	CbGeAlD
Cyclosporine—SLCO1A2—nervous system—leprosy	0.000341	0.00705	CbGeAlD
Cyclosporine—Tinnitus—Thalidomide—leprosy	0.000337	0.00259	CcSEcCtD
Cyclosporine—Angiopathy—Thalidomide—leprosy	0.000328	0.00252	CcSEcCtD
Cyclosporine—Mediastinal disorder—Thalidomide—leprosy	0.000326	0.0025	CcSEcCtD
Cyclosporine—Chills—Thalidomide—leprosy	0.000325	0.00249	CcSEcCtD
Cyclosporine—ABCC2—testis—leprosy	0.000324	0.00669	CbGeAlD
Cyclosporine—Arrhythmia—Thalidomide—leprosy	0.000323	0.00248	CcSEcCtD
Cyclosporine—Alopecia—Thalidomide—leprosy	0.00032	0.00245	CcSEcCtD
Cyclosporine—Vomiting—Dapsone—leprosy	0.000319	0.00245	CcSEcCtD
Cyclosporine—Mental disorder—Thalidomide—leprosy	0.000317	0.00243	CcSEcCtD
Cyclosporine—Malnutrition—Thalidomide—leprosy	0.000315	0.00241	CcSEcCtD
Cyclosporine—Headache—Dapsone—leprosy	0.000315	0.00241	CcSEcCtD
Cyclosporine—Flatulence—Thalidomide—leprosy	0.00031	0.00238	CcSEcCtD
Cyclosporine—Tension—Thalidomide—leprosy	0.000309	0.00237	CcSEcCtD
Cyclosporine—Dysgeusia—Thalidomide—leprosy	0.000309	0.00236	CcSEcCtD
Cyclosporine—Nervousness—Thalidomide—leprosy	0.000306	0.00234	CcSEcCtD
Cyclosporine—Muscle spasms—Thalidomide—leprosy	0.000303	0.00232	CcSEcCtD
Cyclosporine—Nausea—Dapsone—leprosy	0.000298	0.00229	CcSEcCtD
Cyclosporine—Vision blurred—Thalidomide—leprosy	0.000297	0.00227	CcSEcCtD
Cyclosporine—Tremor—Thalidomide—leprosy	0.000295	0.00226	CcSEcCtD
Cyclosporine—Ill-defined disorder—Thalidomide—leprosy	0.000292	0.00224	CcSEcCtD
Cyclosporine—Anaemia—Thalidomide—leprosy	0.000291	0.00223	CcSEcCtD
Cyclosporine—Agitation—Thalidomide—leprosy	0.00029	0.00222	CcSEcCtD
Cyclosporine—Angioedema—Thalidomide—leprosy	0.000288	0.00221	CcSEcCtD
Cyclosporine—ABCC1—testis—leprosy	0.000285	0.00589	CbGeAlD
Cyclosporine—Malaise—Thalidomide—leprosy	0.000284	0.00218	CcSEcCtD
Cyclosporine—Vertigo—Thalidomide—leprosy	0.000283	0.00217	CcSEcCtD
Cyclosporine—Leukopenia—Thalidomide—leprosy	0.000282	0.00216	CcSEcCtD
Cyclosporine—Cough—Thalidomide—leprosy	0.000275	0.00211	CcSEcCtD
Cyclosporine—Convulsion—Thalidomide—leprosy	0.000273	0.00209	CcSEcCtD
Cyclosporine—Hypertension—Thalidomide—leprosy	0.000272	0.00208	CcSEcCtD
Cyclosporine—Chest pain—Thalidomide—leprosy	0.000268	0.00206	CcSEcCtD
Cyclosporine—Myalgia—Thalidomide—leprosy	0.000268	0.00206	CcSEcCtD
Cyclosporine—Arthralgia—Thalidomide—leprosy	0.000268	0.00206	CcSEcCtD
Cyclosporine—Anxiety—Thalidomide—leprosy	0.000267	0.00205	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000266	0.00204	CcSEcCtD
Cyclosporine—Discomfort—Thalidomide—leprosy	0.000265	0.00203	CcSEcCtD
Cyclosporine—Dry mouth—Thalidomide—leprosy	0.000262	0.00201	CcSEcCtD
Cyclosporine—Confusional state—Thalidomide—leprosy	0.000259	0.00199	CcSEcCtD
Cyclosporine—Oedema—Thalidomide—leprosy	0.000257	0.00197	CcSEcCtD
Cyclosporine—Infection—Thalidomide—leprosy	0.000255	0.00196	CcSEcCtD
Cyclosporine—Nervous system disorder—Thalidomide—leprosy	0.000252	0.00193	CcSEcCtD
Cyclosporine—Thrombocytopenia—Thalidomide—leprosy	0.000252	0.00193	CcSEcCtD
Cyclosporine—Skin disorder—Thalidomide—leprosy	0.00025	0.00191	CcSEcCtD
Cyclosporine—Hyperhidrosis—Thalidomide—leprosy	0.000249	0.0019	CcSEcCtD
Cyclosporine—Anorexia—Thalidomide—leprosy	0.000245	0.00188	CcSEcCtD
Cyclosporine—CYP2C8—testis—leprosy	0.000243	0.00502	CbGeAlD
Cyclosporine—ABCG2—testis—leprosy	0.000236	0.00488	CbGeAlD
Cyclosporine—Musculoskeletal discomfort—Thalidomide—leprosy	0.000234	0.00179	CcSEcCtD
Cyclosporine—Insomnia—Thalidomide—leprosy	0.000233	0.00178	CcSEcCtD
Cyclosporine—Paraesthesia—Thalidomide—leprosy	0.000231	0.00177	CcSEcCtD
Cyclosporine—Dyspnoea—Thalidomide—leprosy	0.000229	0.00176	CcSEcCtD
Cyclosporine—Somnolence—Thalidomide—leprosy	0.000229	0.00175	CcSEcCtD
Cyclosporine—Dyspepsia—Thalidomide—leprosy	0.000226	0.00173	CcSEcCtD
Cyclosporine—Decreased appetite—Thalidomide—leprosy	0.000224	0.00171	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Thalidomide—leprosy	0.000222	0.0017	CcSEcCtD
Cyclosporine—Fatigue—Thalidomide—leprosy	0.000222	0.0017	CcSEcCtD
Cyclosporine—Pain—Thalidomide—leprosy	0.00022	0.00168	CcSEcCtD
Cyclosporine—Constipation—Thalidomide—leprosy	0.00022	0.00168	CcSEcCtD
Cyclosporine—Feeling abnormal—Thalidomide—leprosy	0.000212	0.00162	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Thalidomide—leprosy	0.00021	0.00161	CcSEcCtD
Cyclosporine—Urticaria—Thalidomide—leprosy	0.000204	0.00157	CcSEcCtD
Cyclosporine—Abdominal pain—Thalidomide—leprosy	0.000203	0.00156	CcSEcCtD
Cyclosporine—Body temperature increased—Thalidomide—leprosy	0.000203	0.00156	CcSEcCtD
Cyclosporine—Hypersensitivity—Thalidomide—leprosy	0.000189	0.00145	CcSEcCtD
Cyclosporine—Asthenia—Thalidomide—leprosy	0.000184	0.00141	CcSEcCtD
Cyclosporine—Pruritus—Thalidomide—leprosy	0.000182	0.00139	CcSEcCtD
Cyclosporine—Diarrhoea—Thalidomide—leprosy	0.000176	0.00135	CcSEcCtD
Cyclosporine—FKBP1A—Alpha-synuclein signaling—PARK2—leprosy	0.000175	0.0642	CbGpPWpGaD
Cyclosporine—Dizziness—Thalidomide—leprosy	0.00017	0.0013	CcSEcCtD
Cyclosporine—Vomiting—Thalidomide—leprosy	0.000163	0.00125	CcSEcCtD
Cyclosporine—PPIA—Early Phase of HIV Life Cycle—CD4—leprosy	0.000163	0.0597	CbGpPWpGaD
Cyclosporine—Rash—Thalidomide—leprosy	0.000162	0.00124	CcSEcCtD
Cyclosporine—Dermatitis—Thalidomide—leprosy	0.000162	0.00124	CcSEcCtD
Cyclosporine—CYP2D6—testis—leprosy	0.000162	0.00334	CbGeAlD
Cyclosporine—CYP3A4—nervous system—leprosy	0.000161	0.00333	CbGeAlD
Cyclosporine—Headache—Thalidomide—leprosy	0.000161	0.00123	CcSEcCtD
Cyclosporine—PPID—C-MYB transcription factor network—CD4—leprosy	0.000159	0.0584	CbGpPWpGaD
Cyclosporine—CYP2D6—nervous system—leprosy	0.000159	0.00328	CbGeAlD
Cyclosporine—Nausea—Thalidomide—leprosy	0.000153	0.00117	CcSEcCtD
Cyclosporine—PPP3CA—T-Cell Receptor and Co-stimulatory Signaling—CD8A—leprosy	0.000132	0.0482	CbGpPWpGaD
Cyclosporine—ABCB1—testis—leprosy	0.000116	0.0024	CbGeAlD
Cyclosporine—ABCB1—nervous system—leprosy	0.000114	0.00236	CbGeAlD
Cyclosporine—FKBP1A—Calcium signaling in the CD4+ TCR pathway—CD40LG—leprosy	0.000103	0.0378	CbGpPWpGaD
Cyclosporine—FKBP4—Glucocorticoid receptor regulatory network—IFNG—leprosy	7.71e-05	0.0283	CbGpPWpGaD
Cyclosporine—PPP3R2—Alzheimers Disease—TNF—leprosy	7.22e-05	0.0265	CbGpPWpGaD
Cyclosporine—PPP3CA—T-Cell Receptor and Co-stimulatory Signaling—IL2—leprosy	6.95e-05	0.0255	CbGpPWpGaD
Cyclosporine—FKBP4—Glucocorticoid receptor regulatory network—IL2—leprosy	6.85e-05	0.0251	CbGpPWpGaD
Cyclosporine—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IFNG—leprosy	6.07e-05	0.0222	CbGpPWpGaD
Cyclosporine—FKBP1B—Transmembrane transport of small molecules—SLC11A1—leprosy	5.93e-05	0.0217	CbGpPWpGaD
Cyclosporine—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IL2—leprosy	5.39e-05	0.0198	CbGpPWpGaD
Cyclosporine—PPP3CA—Amyotrophic lateral sclerosis (ALS)—TNF—leprosy	4.08e-05	0.015	CbGpPWpGaD
Cyclosporine—PPP3R2—MAPK Signaling Pathway—TNF—leprosy	3.95e-05	0.0145	CbGpPWpGaD
Cyclosporine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	3.74e-05	0.0137	CbGpPWpGaD
Cyclosporine—FKBP1A—TGF-beta Receptor Signaling—IFNG—leprosy	3.69e-05	0.0135	CbGpPWpGaD
Cyclosporine—PPP3CA—C-MYB transcription factor network—CD4—leprosy	3.23e-05	0.0118	CbGpPWpGaD
Cyclosporine—FKBP1B—Integrated Pancreatic Cancer Pathway—TNF—leprosy	3.18e-05	0.0116	CbGpPWpGaD
Cyclosporine—PPP3CA—Cardiac Hypertrophic Response—TNF—leprosy	3.04e-05	0.0111	CbGpPWpGaD
Cyclosporine—SLC10A2—Transmembrane transport of small molecules—SLC11A1—leprosy	2.9e-05	0.0106	CbGpPWpGaD
Cyclosporine—PPIA—Host Interactions of HIV factors—CD4—leprosy	2.81e-05	0.0103	CbGpPWpGaD
Cyclosporine—ABCC10—Transmembrane transport of small molecules—SLC11A1—leprosy	2.72e-05	0.00998	CbGpPWpGaD
Cyclosporine—PPIA—HIV Life Cycle—CD4—leprosy	2.64e-05	0.00968	CbGpPWpGaD
Cyclosporine—PPP3CA—Spinal Cord Injury—IFNG—leprosy	2.55e-05	0.00934	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—CYLD—leprosy	2.46e-05	0.00903	CbGpPWpGaD
Cyclosporine—FKBP1A—TGF-beta Receptor Signaling—TNF—leprosy	2.39e-05	0.00876	CbGpPWpGaD
Cyclosporine—PPP3CA—Alzheimers Disease—TNF—leprosy	2.27e-05	0.00833	CbGpPWpGaD
Cyclosporine—PPP3CA—Spinal Cord Injury—IL2—leprosy	2.26e-05	0.0083	CbGpPWpGaD
Cyclosporine—PPP3CA—MicroRNAs in cardiomyocyte hypertrophy—TNF—leprosy	2.16e-05	0.00793	CbGpPWpGaD
Cyclosporine—FKBP1A—Spinal Cord Injury—IFNG—leprosy	1.97e-05	0.00724	CbGpPWpGaD
Cyclosporine—PPIA—HIV Infection—CD4—leprosy	1.82e-05	0.00669	CbGpPWpGaD
Cyclosporine—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—leprosy	1.81e-05	0.00662	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—SDHD—leprosy	1.8e-05	0.00662	CbGpPWpGaD
Cyclosporine—FKBP1A—Spinal Cord Injury—IL2—leprosy	1.75e-05	0.00643	CbGpPWpGaD
Cyclosporine—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—leprosy	1.7e-05	0.00623	CbGpPWpGaD
Cyclosporine—PPIA—Platelet activation, signaling and aggregation—IL2—leprosy	1.65e-05	0.00604	CbGpPWpGaD
Cyclosporine—PPP3CA—Spinal Cord Injury—TNF—leprosy	1.65e-05	0.00604	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—RIPK2—leprosy	1.59e-05	0.00582	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—TLR2—leprosy	1.59e-05	0.00582	CbGpPWpGaD
Cyclosporine—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—leprosy	1.54e-05	0.00566	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—NOD2—leprosy	1.44e-05	0.00528	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—CYLD—leprosy	1.43e-05	0.00526	CbGpPWpGaD
Cyclosporine—PPIA—Disease—SLC11A1—leprosy	1.41e-05	0.00517	CbGpPWpGaD
Cyclosporine—FKBP1A—Spinal Cord Injury—TNF—leprosy	1.28e-05	0.00469	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—PARK2—leprosy	1.27e-05	0.00465	CbGpPWpGaD
Cyclosporine—PPP3CA—MAPK Signaling Pathway—TNF—leprosy	1.24e-05	0.00455	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—SLC11A1—leprosy	1.17e-05	0.00429	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—SDHD—leprosy	1.16e-05	0.00426	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—CD40LG—leprosy	1.12e-05	0.00411	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—IL10—leprosy	1.12e-05	0.00411	CbGpPWpGaD
Cyclosporine—ABCC3—Transmembrane transport of small molecules—SLC11A1—leprosy	1.05e-05	0.00387	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—RIPK2—leprosy	9.24e-06	0.00339	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—TLR2—leprosy	9.24e-06	0.00339	CbGpPWpGaD
Cyclosporine—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—leprosy	9.18e-06	0.00337	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—SLC11A1—leprosy	9.08e-06	0.00333	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—HLA-DRB1—leprosy	9.02e-06	0.00331	CbGpPWpGaD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—leprosy	8.69e-06	0.00319	CbGpPWpGaD
Cyclosporine—SLC22A6—Transmembrane transport of small molecules—SLC11A1—leprosy	8.63e-06	0.00316	CbGpPWpGaD
Cyclosporine—PPIA—Hemostasis—IL2—leprosy	8.49e-06	0.00311	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—NOD2—leprosy	8.38e-06	0.00307	CbGpPWpGaD
Cyclosporine—ABCC2—Transmembrane transport of small molecules—SLC11A1—leprosy	8.36e-06	0.00306	CbGpPWpGaD
Cyclosporine—ABCC1—Transmembrane transport of small molecules—SLC11A1—leprosy	8.26e-06	0.00303	CbGpPWpGaD
Cyclosporine—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—leprosy	7.85e-06	0.00288	CbGpPWpGaD
Cyclosporine—ABCG2—Transmembrane transport of small molecules—SLC11A1—leprosy	7.27e-06	0.00267	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—CD40LG—leprosy	7.08e-06	0.0026	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—CD8A—leprosy	7.01e-06	0.00257	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—CD4—leprosy	6.91e-06	0.00253	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—SDHD—leprosy	6.85e-06	0.00251	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—IFNG—leprosy	6.59e-06	0.00242	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—SDHD—leprosy	6.57e-06	0.00241	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—RIPK2—leprosy	5.98e-06	0.00219	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—IL2—leprosy	5.86e-06	0.00215	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—SDHD—leprosy	5.72e-06	0.0021	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—HLA-DRB1—leprosy	5.7e-06	0.00209	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—SDHD—leprosy	5.15e-06	0.00189	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—SDHD—leprosy	4.89e-06	0.00179	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—RIPK2—leprosy	4.63e-06	0.0017	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—SLC11A1—leprosy	4.62e-06	0.00169	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—SDHD—leprosy	4.53e-06	0.00166	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—SDHD—leprosy	4.49e-06	0.00165	CbGpPWpGaD
Cyclosporine—PPIA—Disease—CD4—leprosy	4.47e-06	0.00164	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—TNF—leprosy	4.26e-06	0.00156	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—IFNG—leprosy	4.17e-06	0.00153	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—IL2—leprosy	4.05e-06	0.00149	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—CD4—leprosy	4.02e-06	0.00148	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—SLC11A1—leprosy	3.93e-06	0.00144	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—CD4—leprosy	3.71e-06	0.00136	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—IL2—leprosy	3.7e-06	0.00136	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—SDHD—leprosy	3.25e-06	0.00119	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—CD4—leprosy	2.88e-06	0.00106	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—SDHD—leprosy	2.81e-06	0.00103	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—SDHD—leprosy	2.51e-06	0.00092	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—SDHD—leprosy	2.45e-06	0.000898	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—IL2—leprosy	2.39e-06	0.000878	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—SDHD—leprosy	2.31e-06	0.000846	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—SDHD—leprosy	2.29e-06	0.000839	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	2.1e-06	0.000772	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IL2—leprosy	1.86e-06	0.00068	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SDHD—leprosy	1.51e-06	0.000553	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CD4—leprosy	1.47e-06	0.000537	CbGpPWpGaD
